{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":873,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":873,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"32c08eb5d9d0","filters":{"topic":"Neuroblastoma Research and Treatments"}},"results":[{"id":"W2132546867","doi":"10.1038/ng.2529","title":"The genetic landscape of high-risk neuroblastoma","year":2013,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1219,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Human Genome Research Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health","keywords":"ATRX; Biology; Neuroblastoma RAS viral oncogene homolog; PTPN11; Neuroblastoma; Germline mutation; Germline; Exome sequencing; CHEK2; Genetics; Somatic cell; Cancer research; Mutation; Exome; Gene; KRAS","retraction":null,"screen_n_in":null,"score":{"opus":0.005299584076040456,"gpt":0.2492781974386105,"spread":0.2439786133625701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005202012,0.0001367874,0.0001733893,0.00006518593,0.0001059346,0.00002712435,0.0001750138,0.0001515279,0.0001054735],"category_scores_gemma":[0.0001389463,0.0000806095,0.00008185561,0.0002113957,0.0001008771,0.00001761707,0.00007746032,0.0005331635,0.0001654725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001216926,"about_ca_system_score_gemma":0.00007003474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003159455,"about_ca_topic_score_gemma":0.00002250888,"domain_scores_codex":[0.9987904,0.00006063153,0.0001951929,0.0002087337,0.0004271271,0.0003179394],"domain_scores_gemma":[0.998859,0.000147044,0.00008442257,0.0005141093,0.0002182905,0.0001770816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008033321,0.000960662,0.5154228,0.0002132471,0.0008792587,0.0002728586,0.0001664831,0.0001966181,0.03739306,0.0002096291,0.06744231,0.3760398],"study_design_scores_gemma":[0.001348512,0.001114444,0.9635893,0.00001659557,0.00008105984,0.0000759636,0.00001600794,0.0003631781,0.02692886,0.0006104218,0.005778488,0.00007719301],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950973,0.002720326,0.00001751826,0.0006618227,0.0001940374,0.0004913658,0.00001324306,0.00002765466,0.0007766976],"genre_scores_gemma":[0.9956078,0.001450416,0.001771469,0.0001891444,0.0001370481,0.0000264999,0.000005655582,0.0000279423,0.0007840387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4481665,"threshold_uncertainty_score":0.328716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029883816","doi":"10.1172/jci8829","title":"Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1175,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Vinblastine; Pharmacology; Angiogenesis; Chemotherapy; In vivo; Cancer research; Toxicity; Combination therapy; Oncology; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04590777157183174,"gpt":0.3935550668225939,"spread":0.3476472952507622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008316517,0.0001858943,0.0006440822,0.0001157451,0.00008679939,0.00004771095,0.00008291363,0.000103293,0.0001727819],"category_scores_gemma":[0.0009481062,0.00009614868,0.00010972,0.0002078276,0.0003648285,0.0003163587,0.00001645518,0.0006073856,0.00001195369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003572398,"about_ca_system_score_gemma":0.0004073829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001073643,"about_ca_topic_score_gemma":0.000002447406,"domain_scores_codex":[0.9977211,0.0003034935,0.0008976486,0.0002330525,0.0006127362,0.00023193],"domain_scores_gemma":[0.9978765,0.000355718,0.0005933634,0.0001708666,0.0004021726,0.0006013373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0282867,0.001875063,0.696634,0.0001156083,0.0004281654,0.001053616,0.0002463002,0.000006641988,0.1800246,0.00001974702,0.001771838,0.08953769],"study_design_scores_gemma":[0.02207682,0.01920178,0.8614631,0.001951313,0.0001220545,0.0007841135,0.000113306,0.0002517466,0.09165967,0.0003937284,0.001760295,0.0002220448],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966091,0.000131175,0.000009851979,0.00259088,0.00008748462,0.0003323567,0.00000268163,0.00002061764,0.0002158333],"genre_scores_gemma":[0.9959594,0.0007298726,0.001294823,0.0008931853,0.0004242113,0.000002869275,0.00001087389,0.00002347515,0.0006612969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1648291,"threshold_uncertainty_score":0.392083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2286322195","doi":"10.1016/j.cell.2016.01.015","title":"New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs","year":2016,"lang":"en","type":"article","venue":"Cell","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1009,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"School of Medicine, University of Missouri; National Center for Advancing Translational Sciences; Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft; National Institutes of Health; Hospital for Sick Children; Deutsche Krebshilfe; Bundesministerium für Bildung und Forschung; Deutsche Kinderkrebsstiftung; Institut National Du Cancer; Cancer Research UK; Brain Tumour Charity; Rosetrees Trust; National Cancer Institute; Making Headway Foundation; Deutsches Krebsforschungszentrum; St. Jude Children's Research Hospital","keywords":"Biology; Neuroepithelial cell; Central nervous system; Neuroblastoma; Pathology; Brain tumor; Neuroscience; Stem cell; Medicine; Neural stem cell; Genetics; Cell culture","retraction":null,"screen_n_in":null,"score":{"opus":0.01894804525880438,"gpt":0.2740198097670117,"spread":0.2550717645082073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002830243,0.00006928446,0.0001146949,0.00005387864,0.00001301521,0.000004063052,0.00005801781,0.00002161938,0.0009986326],"category_scores_gemma":[0.00005016071,0.00004592526,0.00005407034,0.00005815977,0.00003243248,0.00003880799,0.00002245126,0.00003641267,0.0003383104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002409374,"about_ca_system_score_gemma":0.00008052948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001090628,"about_ca_topic_score_gemma":0.000008581672,"domain_scores_codex":[0.9993575,0.00002762535,0.0001203898,0.0001512813,0.0002012747,0.0001419524],"domain_scores_gemma":[0.9994841,0.00005441825,0.00004511622,0.0002374519,0.00004004914,0.0001389084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008144031,0.0001028576,0.002533753,0.00002022715,0.00002716917,0.00007577393,0.0000304151,3.645249e-8,0.9780821,0.00009072071,0.01538388,0.003571595],"study_design_scores_gemma":[0.001928719,0.0002563082,0.04898152,0.00005687169,0.00002633537,0.000002385904,0.00002032699,0.000007376883,0.9395212,0.0005333157,0.008618081,0.00004759139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897299,0.00021522,0.000829612,0.00157502,0.00006181088,0.0001629944,0.00002421341,0.00002220974,0.007378967],"genre_scores_gemma":[0.985109,0.0000287162,0.0003971315,0.0001076447,0.00004375292,0.000006094625,0.00001854473,0.00001318054,0.01427591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04644777,"threshold_uncertainty_score":0.9999146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060275730","doi":"10.1038/nature07397","title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","year":2008,"lang":"en","type":"article","venue":"Nature","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":892,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Neuroblastoma; Anaplastic lymphoma kinase; Cancer research; Biology; Gene knockdown; Molecular biology; Small hairpin RNA; Mutation; Tyrosine kinase; Cell culture; Gene; Signal transduction; Cell biology; Genetics; Medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01921542182137839,"gpt":0.3121136169284821,"spread":0.2928981951071037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005212024,0.0001091894,0.0001583576,0.0002658861,0.00004930335,0.000006622679,0.00006123607,0.0002570699,0.0000376455],"category_scores_gemma":[0.0002106003,0.00008914456,0.00004017624,0.0005474511,0.00003927907,0.0001033022,0.00002191406,0.001842928,0.00002529037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008926969,"about_ca_system_score_gemma":0.0001653299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003372517,"about_ca_topic_score_gemma":0.00007991389,"domain_scores_codex":[0.9990206,0.0000596038,0.0001388743,0.0002236002,0.0002719883,0.000285343],"domain_scores_gemma":[0.9995871,0.0001105721,0.00002913226,0.0001502745,0.00003807235,0.00008490955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002438428,0.003822256,0.7118699,0.0002647566,0.0001649756,0.02305209,0.003565188,0.0002845452,0.2148187,0.0003570409,0.002062215,0.03729995],"study_design_scores_gemma":[0.00450461,0.0005313223,0.9630328,0.0001264579,0.000006802647,0.0004889957,0.00008037811,0.0007908565,0.02587683,0.0003668657,0.004068604,0.0001254298],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945974,0.0002612271,0.000004860216,0.002113752,0.00003781972,0.0004709004,0.000003783135,0.00003962891,0.002470664],"genre_scores_gemma":[0.9978169,0.00002010398,0.000521238,0.001002448,0.00003426226,0.00005017368,0.00001453413,0.00002029109,0.0005200503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2511629,"threshold_uncertainty_score":0.8006707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2124343455","doi":"10.3332/ecancer.2014.463","title":"ecancermedicalscience","year":2016,"lang":"en","type":"article","venue":"ecancermedicalscience","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":679,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Repurposing; Cancer; Clinical Practice; Oncology; Intensive care medicine; Internal medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01494786441112387,"gpt":0.3209219483150048,"spread":0.3059740839038809,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004189225,0.0001590228,0.0002474915,0.0001421765,0.000177694,0.00002145798,0.0003714105,0.00006261212,0.002931901],"category_scores_gemma":[0.001134192,0.0000818332,0.0000871594,0.0007315149,0.002029921,0.0002442523,0.0001280234,0.0001416171,0.0009248526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002647087,"about_ca_system_score_gemma":0.001063172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001792532,"about_ca_topic_score_gemma":0.000008431517,"domain_scores_codex":[0.9968271,0.00003847422,0.0002549333,0.0006244312,0.001462809,0.0007922224],"domain_scores_gemma":[0.9980662,0.0002019714,0.00006010132,0.0004766101,0.0001087258,0.001086395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002350031,0.0004347422,0.03230915,0.00004568621,0.00003163796,0.0007792137,0.00007439748,2.98519e-7,0.1640215,0.001953618,0.02231708,0.7777976],"study_design_scores_gemma":[0.0105323,0.003131928,0.5706483,0.001575177,0.00006769678,0.001397363,0.00005207595,0.0003956997,0.1282636,0.004745171,0.2784411,0.000749621],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8963882,0.0004175162,0.00853836,0.04810558,0.001077502,0.0007871422,0.00002822032,0.0004193579,0.04423812],"genre_scores_gemma":[0.9905738,0.0004673923,0.000674658,0.001867982,0.000235166,0.00006827134,6.976827e-7,0.0000134321,0.006098555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.777048,"threshold_uncertainty_score":0.999853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101042741","doi":"10.1200/jco.2005.05.571","title":"Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Cutoff; Neuroblastoma; Stage (stratigraphy); Internal medicine; Pediatric oncology; Risk stratification; Cancer; Oncology; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.2710879266510203,"gpt":0.512960278752268,"spread":0.2418723521012477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005660191,0.0002046363,0.001069169,0.0002037121,0.0001192332,0.00003299182,0.0004469731,0.0003610106,0.00002514321],"category_scores_gemma":[0.005210136,0.0001222639,0.0005482553,0.0001657523,0.0002652195,0.0003908077,0.00003874181,0.001129817,0.00001343256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002100669,"about_ca_system_score_gemma":0.0006359004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003292779,"about_ca_topic_score_gemma":0.001096556,"domain_scores_codex":[0.9952312,0.00152698,0.001961012,0.0003938891,0.0004146583,0.0004722422],"domain_scores_gemma":[0.989737,0.00784553,0.001352026,0.0003882605,0.0002761446,0.0004009974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04625861,0.0137581,0.1524593,0.00006576139,0.0005818277,0.0009595686,0.000606426,0.00005802736,0.002463565,0.0006454189,0.007389972,0.7747535],"study_design_scores_gemma":[0.01435549,0.112805,0.8539441,0.0000886462,0.0004332346,0.0008493941,0.00008506046,0.0005047241,0.000137762,0.0009272398,0.0157591,0.000110218],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860043,0.0001220576,0.001168695,0.01030455,0.0003887737,0.001695265,0.0000216842,0.00001312978,0.0002815273],"genre_scores_gemma":[0.9865012,0.0005723559,0.00843457,0.002216334,0.002030361,0.0001227205,0.00002203076,0.00002866274,0.00007176922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7746432,"threshold_uncertainty_score":0.6237396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2213548494","doi":"10.1038/ng.3333","title":"Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations","year":2015,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":555,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Universiteit van Amsterdam; Fondation Nelia et Amadeo Barletta; Agence Nationale de la Recherche; National Institute on Minority Health and Health Disparities; Annenberg Foundation","keywords":"Biology; Neuroblastoma; MAPK/ERK pathway; Cancer research; Somatic cell; Phenotype; Mutation; In vivo; Germline mutation; Genotype; Genetics; Cell culture; Signal transduction; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02693391353906878,"gpt":0.3070803402388448,"spread":0.280146426699776,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052998,0.00020762,0.0002221882,0.0001639461,0.00007626673,0.000034824,0.0001409838,0.0002651381,0.00005474165],"category_scores_gemma":[0.0003795345,0.0001720113,0.0001022555,0.0003441805,0.00008359383,0.0000454075,0.00007068795,0.0008030872,0.0003011994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001212739,"about_ca_system_score_gemma":0.0004313861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004789284,"about_ca_topic_score_gemma":0.00002073378,"domain_scores_codex":[0.9982224,0.00007345695,0.0002073254,0.0003636257,0.0007198725,0.0004133116],"domain_scores_gemma":[0.9984079,0.00006300482,0.00005629777,0.0004910922,0.0003356902,0.0006460159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004710305,0.008555729,0.1460839,0.0006475509,0.002082756,0.01278983,0.003475404,0.001386167,0.4395563,0.003062647,0.2886852,0.08896418],"study_design_scores_gemma":[0.0220223,0.00896548,0.149576,0.0002271532,0.0004735434,0.001631693,0.0003139525,0.001502871,0.3999221,0.003981756,0.4104097,0.0009734938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860207,0.001751086,0.0001159467,0.001915584,0.0006991701,0.0006696552,0.00005168757,0.0001567117,0.008619391],"genre_scores_gemma":[0.9914727,0.0000646986,0.004291649,0.0009668928,0.0002461838,0.00003117307,0.0001007389,0.00005113324,0.00277483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1217245,"threshold_uncertainty_score":0.7014419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3184057816","doi":"10.1200/jco.21.00278","title":"Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Neuroblastoma; Medicine; Cog; Oncology; Histology; Internal medicine; Stage (stratigraphy); Disease; Pathology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1226237096784024,"gpt":0.4633957730206369,"spread":0.3407720633422346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00362392,0.0001786343,0.001540843,0.00007686085,0.0001269826,0.00002404291,0.0002629314,0.0004021599,0.0001341047],"category_scores_gemma":[0.01500775,0.0001045643,0.0007806037,0.0002791758,0.0002776123,0.0001011624,0.0001177189,0.00203736,0.0001070418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003380319,"about_ca_system_score_gemma":0.003150144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006485023,"about_ca_topic_score_gemma":0.00008056469,"domain_scores_codex":[0.9926074,0.003106656,0.002896391,0.0004037699,0.0006665126,0.0003192878],"domain_scores_gemma":[0.9880137,0.00667348,0.003249959,0.0006411496,0.0008310878,0.0005906643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01043694,0.007115802,0.5792899,0.00004646507,0.002889827,0.07559879,0.00007916457,0.000004733643,0.003010642,0.0002587178,0.04071562,0.2805534],"study_design_scores_gemma":[0.008341029,0.009534642,0.893884,0.0001415895,0.0009537801,0.0171172,0.0001579559,0.00007305427,0.0001491091,0.0000961777,0.06947884,0.00007263783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770829,0.0005142575,0.0002092664,0.01539474,0.001499491,0.0003732105,0.00001829896,0.00002691516,0.004880928],"genre_scores_gemma":[0.9918235,0.001424324,0.002183836,0.001862847,0.002382809,0.00001089425,0.00003256756,0.00002725471,0.0002519957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3145941,"threshold_uncertainty_score":0.9932893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W145418528","doi":"10.1016/j.pcl.2014.09.015","title":"Neuroblastoma","year":2014,"lang":"en","type":"review","venue":"Pediatric Clinics of North America","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Neuroblastoma; Radiation therapy; Chemotherapy; Pediatric cancer; Oncology; Clinical trial; Internal medicine; Cancer; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.04734969217714067,"gpt":0.3865380495766112,"spread":0.3391883573994705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001460518,0.0005606162,0.003471805,0.0006134617,0.00005265906,0.00001274444,0.0003913947,0.0001912096,0.0001039016],"category_scores_gemma":[0.0009631227,0.000433126,0.001425646,0.001299193,0.0001572848,0.00003641154,0.0002265862,0.000874745,0.001132741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005065699,"about_ca_system_score_gemma":0.0009518683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001223689,"about_ca_topic_score_gemma":0.000003938927,"domain_scores_codex":[0.9963294,0.0002211377,0.001457963,0.0007119295,0.0007037036,0.0005759072],"domain_scores_gemma":[0.9955842,0.001392958,0.001210828,0.00103639,0.000192419,0.0005832018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000480758,0.0004539291,0.001878863,0.01679663,0.0001973163,0.0001904374,0.000002883447,4.741626e-7,2.975121e-9,7.26609e-7,0.002786922,0.9776437],"study_design_scores_gemma":[0.0006292131,0.002078678,0.0007781007,0.0006426614,0.003254456,0.00009011378,4.450837e-7,0.000007403728,3.285605e-8,0.000002808612,0.9922635,0.0002525768],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005426308,0.9970077,0.00002774218,0.0000257247,0.0002873861,0.001105304,0.0001802405,0.00008996703,0.000733301],"genre_scores_gemma":[0.00007695795,0.9973351,0.0004489697,0.0001229876,0.0009321365,0.00007986209,0.0003203147,0.0001261523,0.0005574598],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9894766,"threshold_uncertainty_score":0.9998121,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995294036","doi":"10.1056/nejmoa012387","title":"Screening of Infants and Mortality Due to Neuroblastoma","year":2002,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":356,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal Children's Hospital; Centre Hospitalier Universitaire de Sherbrooke; Canadian Medical Association; Hospital for Sick Children; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; Statistics Canada","funders":"National Cancer Institute","keywords":"Neuroblastoma; Medicine; Confidence interval; Cohort; Incidence (geometry); Standardized mortality ratio; Pediatrics; Rate ratio; Mortality rate; Demography; Cohort study; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04688130828961368,"gpt":0.319993884786906,"spread":0.2731125764972923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003720644,0.000125671,0.0005251212,0.0002963874,0.0000292015,0.000004870991,0.00007842234,0.00003264561,0.0003042156],"category_scores_gemma":[0.0006622006,0.00007992994,0.00005184882,0.0002295018,0.00009505653,0.00007695777,0.00003454853,0.00026306,0.000004138979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000127668,"about_ca_system_score_gemma":0.00003470608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007383007,"about_ca_topic_score_gemma":0.00001922848,"domain_scores_codex":[0.9985124,0.00006865452,0.0004558332,0.0001238705,0.0006333045,0.0002058916],"domain_scores_gemma":[0.9985732,0.0001766062,0.0001849439,0.0001631634,0.0001576413,0.0007443958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003792762,0.0004323349,0.1409213,0.0001736503,0.0006198196,0.009913022,0.001786411,0.00002741252,0.04875115,0.00004814751,0.01586922,0.7776647],"study_design_scores_gemma":[0.09091143,0.01814749,0.8542694,0.001586357,0.0004324444,0.01564782,0.0001011585,0.0002917218,0.008486217,0.000190697,0.00978379,0.0001514374],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928541,0.0006221829,0.0003439438,0.004755388,0.0001213833,0.0001466831,0.000002470505,0.000007069923,0.001146813],"genre_scores_gemma":[0.9972501,0.000236225,0.0008533158,0.000478376,0.0008232683,5.426776e-7,6.800325e-7,0.00001343852,0.0003440523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7775133,"threshold_uncertainty_score":0.3330948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206379059","doi":"10.1038/s41591-021-01625-x","title":"Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication","year":2022,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Deutsche Krebshilfe; Wellcome Trust; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Southern California; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"CD47; Blockade; Calreticulin; Cancer research; Monoclonal antibody; Neuroblastoma; Medicine; Macrophage; Immunotherapy; Tumor microenvironment; Immunology; Cancer; Antibody; Biology; Receptor; Immune system; Internal medicine; Cell culture; Cell biology; Tumor cells","retraction":null,"screen_n_in":null,"score":{"opus":0.006035995999071824,"gpt":0.2871763778405188,"spread":0.281140381841447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002761062,0.0002180254,0.0004277408,0.000417886,0.0002259374,0.000007016711,0.0001935673,0.00005936997,0.001035939],"category_scores_gemma":[0.0003321054,0.0001394896,0.00004413521,0.000946406,0.0001200526,0.00004368164,0.0001021533,0.001132391,0.0000600797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000182797,"about_ca_system_score_gemma":0.0001900058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004369764,"about_ca_topic_score_gemma":0.00001570863,"domain_scores_codex":[0.9973845,0.00009077082,0.0002203223,0.0004540397,0.001423815,0.0004265561],"domain_scores_gemma":[0.9986849,0.0001229964,0.00007944641,0.0004536854,0.0001306327,0.0005282707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01339195,0.003688258,0.06979351,0.0006899667,0.001822467,0.03017308,0.003562249,0.0002628503,0.5292164,0.00162853,0.3188912,0.02687954],"study_design_scores_gemma":[0.03106533,0.02776248,0.3044361,0.0007851262,0.0009776714,0.006064527,0.001156823,0.0003492812,0.09779056,0.0002626744,0.5285005,0.0008489585],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9511656,0.001460664,0.00002140356,0.04327749,0.0003218629,0.0008755765,0.00002676142,0.0001358052,0.002714834],"genre_scores_gemma":[0.9902234,0.00004617115,0.0004003325,0.006019255,0.000508023,0.0001912005,0.0001349749,0.00004524559,0.002431388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4314258,"threshold_uncertainty_score":0.9998773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122250312","doi":"10.1200/jco.2011.37.9990","title":"Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Asymptomatic; Chemotherapy; Neuroblastoma; Stage (stratigraphy); Surgery; Disease; Internal medicine; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.08496636381527489,"gpt":0.41899630753716,"spread":0.3340299437218851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002141642,0.0002813135,0.002806379,0.0003906947,0.00003933411,0.000006298034,0.0001641816,0.000294255,0.00004004525],"category_scores_gemma":[0.007533378,0.0001475828,0.0004442843,0.0004084737,0.0003861009,0.0002833414,0.00006006436,0.0008792611,0.000002645384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001306065,"about_ca_system_score_gemma":0.001081998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006346592,"about_ca_topic_score_gemma":0.0001412253,"domain_scores_codex":[0.9936907,0.001115377,0.003534947,0.0003097394,0.0008083815,0.0005408382],"domain_scores_gemma":[0.9822797,0.01146853,0.004062782,0.0004184253,0.001099393,0.0006711739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2721508,0.03302577,0.6790655,0.00003652184,0.001151877,0.0003560711,0.00007547257,0.000002447664,0.00001792109,3.579029e-7,0.0006812754,0.01343597],"study_design_scores_gemma":[0.05626827,0.1670244,0.7747311,0.00008702167,0.0007041712,0.0001351177,0.00002755916,0.000003207431,0.000101539,0.000001573349,0.0008195859,0.00009647107],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974502,0.00002419662,0.00003757289,0.0005277283,0.0003228099,0.001520973,0.00008979045,0.000009926048,0.00001682038],"genre_scores_gemma":[0.9952076,0.0001331812,0.00370579,0.0004433926,0.000340168,0.00003097045,0.00001406564,0.00005356182,0.00007127261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2158826,"threshold_uncertainty_score":0.9018701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969402650","doi":"10.1158/0008-5472.can-06-2117","title":"Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Neuroblastoma; Doxorubicin; Cancer research; Medicine; Angiogenesis; Cancer; Pharmacology; Chemotherapy; Biology; Internal medicine; Cell culture","retraction":null,"screen_n_in":null,"score":{"opus":0.02772456210869785,"gpt":0.3278074989992909,"spread":0.3000829368905931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005456131,0.0003419239,0.0004569389,0.0004110176,0.0004858208,0.0002243765,0.0002538623,0.00009196118,0.0006640517],"category_scores_gemma":[0.00002017032,0.0002711159,0.0001650952,0.0007858163,0.0004418995,0.0001458005,0.0001225334,0.0009492608,0.000133433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002760277,"about_ca_system_score_gemma":0.0002353182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002493451,"about_ca_topic_score_gemma":0.000007927312,"domain_scores_codex":[0.9960337,0.0001610118,0.0003498999,0.0008545627,0.001311587,0.001289182],"domain_scores_gemma":[0.9983861,0.0002383878,0.00007016373,0.0005416934,0.0003309829,0.0004326882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002181373,0.001101999,0.01192183,0.0002183085,0.000179412,0.001115597,0.0001473962,0.00001563607,0.9601753,0.0001081527,0.01304807,0.009786926],"study_design_scores_gemma":[0.01544012,0.002201391,0.193903,0.0003625148,0.00006311996,0.000274206,0.0001597658,0.0002977606,0.7302408,0.0007206146,0.055707,0.0006297709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9621384,0.03432686,0.00004578776,0.001000503,0.0001252349,0.00118425,0.00001641133,0.0001103164,0.001052232],"genre_scores_gemma":[0.9931586,0.003379385,0.000211905,0.0001862837,0.0008729892,0.0001733697,0.00003716711,0.0001239351,0.001856395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2299345,"threshold_uncertainty_score":0.9999741,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2725857922","doi":"10.1158/1078-0432.ccr-17-0652","title":"Retinoblastoma and Neuroblastoma Predisposition and Surveillance","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; American Association for Cancer Research","keywords":"Retinoblastoma; Neuroblastoma; Medicine; Genetic predisposition; Pathology; Biology; Cancer research; Genetics; Gene; Disease; Cell culture","retraction":null,"screen_n_in":null,"score":{"opus":0.5637842129581868,"gpt":0.6469697183172912,"spread":0.0831855053591044,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002632755,0.0004566076,0.002328292,0.0004005046,0.0005085987,0.0002475857,0.0003621308,0.0005515849,0.000110006],"category_scores_gemma":[0.00240504,0.0003389021,0.0003756429,0.0002935587,0.001762196,0.000119378,0.0008212721,0.00273906,0.0001314623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001577788,"about_ca_system_score_gemma":0.001193049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008519149,"about_ca_topic_score_gemma":0.00008355163,"domain_scores_codex":[0.9941537,0.001538833,0.0009104116,0.001406899,0.00106236,0.000927766],"domain_scores_gemma":[0.9946476,0.002374818,0.0003003946,0.001159721,0.0004078058,0.001109696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005237011,0.0001916293,0.001282422,0.01172091,0.0002627748,0.0008126374,0.00000561457,7.099296e-9,0.000001285303,0.00001794798,0.003371304,0.9818097],"study_design_scores_gemma":[0.001621396,0.002672813,0.01269193,0.01152016,0.0002118,0.0004494789,0.000002708083,0.00001357052,0.000001813345,0.00003822447,0.9705229,0.0002532464],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005046093,0.9903138,5.638317e-7,0.0006163867,0.0002326833,0.002229975,0.0001749701,0.00006193775,0.00132362],"genre_scores_gemma":[0.001908706,0.9933025,0.00003394606,0.00004935913,0.000827504,0.0004891757,0.00004315325,0.0001128105,0.003232839],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9815565,"threshold_uncertainty_score":0.9999063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2754294524","doi":"10.1016/j.ccell.2017.08.003","title":"Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency; SickKids Foundation; Hospital for Sick Children","funders":"National Institutes of Health; National Institute of General Medical Sciences; Alex's Lemonade Stand Foundation for Childhood Cancer; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Neuroblastoma; Identification (biology); Cancer research; Biology; Computational biology; Cell culture; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01165331880939907,"gpt":0.3126967280895578,"spread":0.3010434092801587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110784,0.0001057609,0.0001938203,0.00006273724,0.000105441,0.00003873002,0.0001280628,0.00004188535,0.000117765],"category_scores_gemma":[0.00002634049,0.00009262302,0.00002639854,0.00004384948,0.00011455,0.000190581,0.00003979069,0.0001287169,0.00001840219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007877988,"about_ca_system_score_gemma":0.0001280412,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01183376,"about_ca_topic_score_gemma":0.001430963,"domain_scores_codex":[0.9991248,0.00005567415,0.0001937753,0.0002571846,0.0001734177,0.0001951234],"domain_scores_gemma":[0.9990783,0.0000155613,0.0001953809,0.0005427609,0.00005133809,0.0001166207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001464851,0.0005292344,0.1212698,0.0002154263,0.00007367598,0.00016695,0.0004233332,0.00001387961,0.8439469,0.00004085897,0.00004764241,0.03180744],"study_design_scores_gemma":[0.003211851,0.0007647309,0.4754767,0.00005918518,0.00003549221,0.000006703568,0.00002695924,0.0002421747,0.5195553,0.0002861335,0.00026144,0.00007337124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981706,0.0006742997,0.000008072177,0.0001865231,0.00008563161,0.0004242114,0.00003832771,0.00001249196,0.0003998451],"genre_scores_gemma":[0.9974922,0.001272169,0.00005192894,0.00005291805,0.00003436393,0.00006323776,0.000007772775,0.00002238167,0.001003013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3542069,"threshold_uncertainty_score":0.9947465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126177906","doi":"10.1093/jnci/djp230","title":"Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study","year":2009,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of Alberta; Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Cumulative incidence; Neuroblastoma; Confidence interval; Cohort; Incidence (geometry); Pediatrics; Sibling; Poisson regression; Cancer; Cohort study; Internal medicine; Population; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.05643377881008291,"gpt":0.3854253000697375,"spread":0.3289915212596546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885332,0.0001696138,0.0004322196,0.0001654334,0.00009697449,0.00002199561,0.0003926484,0.00004112992,0.00005209141],"category_scores_gemma":[0.0005951461,0.00008631955,0.0002335186,0.0004545128,0.000100346,0.0002263003,0.00006261247,0.0004857351,0.000001778477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000335251,"about_ca_system_score_gemma":0.001224872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002216864,"about_ca_topic_score_gemma":0.01407389,"domain_scores_codex":[0.9971269,0.0001408385,0.0007111514,0.000184789,0.001632799,0.0002034769],"domain_scores_gemma":[0.9982814,0.0001832566,0.0005975968,0.0002307889,0.0006021734,0.0001048067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000522221,0.001676485,0.9927556,0.000007369234,0.0004408054,0.0006101203,0.0003250029,0.0005625939,0.0007726545,0.00001082234,0.0005045253,0.001811811],"study_design_scores_gemma":[0.003538287,0.0003959067,0.9940365,0.0001939762,0.0001265655,0.0002517102,0.00002263194,0.000007136487,0.001056053,0.0001224252,0.0001828413,0.00006599163],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905896,0.0003448153,0.000003612553,0.007086273,0.001136975,0.0005677385,0.00007818978,0.000005776464,0.0001870833],"genre_scores_gemma":[0.9983273,0.0001293883,0.0000212501,0.0007950682,0.0004284042,0.00001835244,0.0000031812,0.00001156366,0.0002655124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01185703,"threshold_uncertainty_score":0.7853562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168659791","doi":"10.1158/0008-5472.can-07-0718","title":"Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Neuroblastoma; Bone marrow; Neural crest; Pathology; Cancer research; Primary tumor; Minimal residual disease; Biology; Cancer; Medicine; Metastasis; Internal medicine; Cell culture; Cell biology; Embryo","retraction":null,"screen_n_in":null,"score":{"opus":0.04306065587262296,"gpt":0.3702739728556713,"spread":0.3272133169830483,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001289331,0.000330397,0.0005371202,0.0006242053,0.0003292824,0.0001159952,0.0003091346,0.0001157516,0.00133222],"category_scores_gemma":[0.0004141113,0.000280936,0.0001756855,0.001179893,0.0002601446,0.000186086,0.0002657399,0.001544501,0.0004519072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004799657,"about_ca_system_score_gemma":0.0006869204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002070899,"about_ca_topic_score_gemma":0.0004910183,"domain_scores_codex":[0.9949184,0.0004711221,0.0005026926,0.0008135706,0.001643054,0.001651149],"domain_scores_gemma":[0.9963297,0.001316566,0.0001149423,0.0006120112,0.0007146552,0.0009121845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003666678,0.0004472577,0.001165409,0.0001209847,0.0001617641,0.00963635,0.0001639928,0.000004254212,0.9770721,0.00001881359,0.00419278,0.003349568],"study_design_scores_gemma":[0.006678887,0.002235468,0.01147152,0.0002098421,0.00008563369,0.00009998294,0.0004182442,0.000266438,0.9742284,0.0001288444,0.003863638,0.0003130392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929094,0.001831589,0.00008831021,0.0005997642,0.000188144,0.001168883,0.000172818,0.0001414717,0.002899665],"genre_scores_gemma":[0.9956946,0.0001938556,0.0005357767,0.0006382745,0.0003194267,0.0001188722,0.00008178804,0.00009923417,0.002318203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01030611,"threshold_uncertainty_score":0.9999643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143660636","doi":"10.1111/j.1365-3016.2008.00983.x","title":"The epidemiology of neuroblastoma: a review","year":2008,"lang":"en","type":"review","venue":"Paediatric and Perinatal Epidemiology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences","keywords":"Medicine; Epidemiology; Neuroblastoma; Disease; Cohort study; Pregnancy; Population; Environmental health; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1132450901244594,"gpt":0.4206397767962182,"spread":0.3073946866717588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002041649,0.0006088123,0.005874238,0.0002260497,0.000232592,0.000001275834,0.0003272293,0.0004559965,0.0000428893],"category_scores_gemma":[0.02265179,0.0003243914,0.001185036,0.0005173605,0.001047215,0.00003316837,0.0003721425,0.001106714,0.0001118381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000621328,"about_ca_system_score_gemma":0.0004844711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003720983,"about_ca_topic_score_gemma":0.000002463097,"domain_scores_codex":[0.9926589,0.003376581,0.002055212,0.0008058397,0.0001600651,0.0009434474],"domain_scores_gemma":[0.9696903,0.02790884,0.001054497,0.0007694854,0.0001084091,0.0004685213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005848338,0.00005258487,0.0009504355,0.05118546,0.0003173296,0.0002578886,0.000002832774,5.044017e-8,1.700354e-8,0.0006502374,0.01181209,0.9347126],"study_design_scores_gemma":[0.0003764056,0.001005571,0.0009753813,0.005724559,0.0007655227,0.008365502,9.139089e-7,0.000005933656,4.483887e-8,0.0001502673,0.9824402,0.0001897083],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000217987,0.996177,0.00001196616,0.001597669,0.0002267926,0.001449426,0.00008811916,0.00003801931,0.0003892172],"genre_scores_gemma":[0.00001405794,0.997354,0.0002881395,0.000895814,0.0003080874,0.0003028272,0.00008308033,0.00005787342,0.0006961677],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9706281,"threshold_uncertainty_score":0.9999208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2961969123","doi":"10.1038/s41568-019-0169-x","title":"Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours","year":2019,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"World Health Organization","keywords":"Computational biology; Medicine; Cancer research; Biology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04916384748397009,"gpt":0.4341655619739588,"spread":0.3850017144899887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003985172,0.0007778997,0.003873887,0.0001706465,0.00009419541,0.00007590606,0.0002382027,0.0007618907,0.0001141621],"category_scores_gemma":[0.0003041114,0.0004883353,0.0008512512,0.0005072731,0.0001409579,0.00005047043,0.000149944,0.002410472,0.0002064904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003270199,"about_ca_system_score_gemma":0.0006271754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008727445,"about_ca_topic_score_gemma":0.000004167961,"domain_scores_codex":[0.9967826,0.0003942604,0.0007671354,0.0008299602,0.0005273967,0.000698662],"domain_scores_gemma":[0.9979808,0.0002455313,0.0004762936,0.0008029508,0.0001597636,0.0003346688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002110987,0.00006799057,0.00009733078,0.07454833,0.0003399025,0.000154477,0.00002105412,2.306949e-8,0.000002925415,0.00002583831,0.0004983563,0.9242226],"study_design_scores_gemma":[0.0004852572,0.0002070013,0.0001556917,0.01898184,0.002736933,0.0002209156,0.000003447801,0.00000128643,0.000006670576,0.00001114607,0.9768251,0.0003646789],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002338353,0.9948624,0.000001523195,0.0001215043,0.0005682394,0.003592443,0.0004163756,0.00004482401,0.0001588029],"genre_scores_gemma":[0.0004766714,0.9960613,0.00002982502,0.0006968974,0.0005741343,0.0007899805,0.0001867902,0.000141756,0.001042632],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9763268,"threshold_uncertainty_score":0.999891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810818134","doi":"10.1007/s00259-018-4070-8","title":"Guidelines on nuclear medicine imaging in neuroblastoma","year":2018,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Neuroblastoma; Nuclear medicine imaging; Medical physics; Nuclear medicine; Clinical Practice; Radiology; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03276467106406806,"gpt":0.3307028953573262,"spread":0.2979382242932581,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001101298,0.0002904574,0.0005235847,0.0008114754,0.0001162995,0.00002862265,0.0002209798,0.00001547943,0.0002294054],"category_scores_gemma":[0.001130543,0.0002034795,0.00009696966,0.0003316356,0.0006444728,0.0001532219,0.0001219297,0.0005238806,0.00008591797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005207503,"about_ca_system_score_gemma":0.00003933136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001847912,"about_ca_topic_score_gemma":6.918753e-7,"domain_scores_codex":[0.997348,0.0003273682,0.0008354744,0.0003456947,0.000712427,0.0004310071],"domain_scores_gemma":[0.9983377,0.00006102381,0.0002916391,0.0003276238,0.0004785216,0.0005034381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002556151,0.0003667424,0.00280912,0.0001167405,0.0001676567,0.08784781,0.00292183,0.000004482261,0.5127996,0.0004451062,0.2409517,0.149013],"study_design_scores_gemma":[0.03146553,0.01739192,0.04602098,0.009589131,0.0005002475,0.02234012,0.003771239,0.002860036,0.002257737,0.0001991425,0.8629492,0.0006547442],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7880495,0.001362024,0.0001020096,0.1647097,0.0004709573,0.0002714367,0.000001352754,0.00006793019,0.04496501],"genre_scores_gemma":[0.9529801,0.0003661598,0.0009761698,0.04452055,0.0009828291,2.529253e-7,0.000001272758,0.0001288008,0.00004385039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6219974,"threshold_uncertainty_score":0.8297654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2735902464","doi":"10.1002/cncr.30873","title":"Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Neuroblastoma; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Disease; Chemotherapy; Cancer; Genetics; Biology; Cell culture","retraction":null,"screen_n_in":null,"score":{"opus":0.01967968440705006,"gpt":0.3996647990397395,"spread":0.3799851146326895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002640802,0.0001097996,0.000410927,0.00001878197,0.00008579641,0.0000161693,0.0001136081,0.00009172233,0.00003925894],"category_scores_gemma":[0.0005967588,0.000060431,0.00005643105,0.00003816314,0.0002496343,0.00005148011,0.0000823329,0.0003459503,0.000005208401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009991767,"about_ca_system_score_gemma":0.000174496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002741958,"about_ca_topic_score_gemma":0.004785577,"domain_scores_codex":[0.9989704,0.0001291853,0.0002515516,0.0002876453,0.0001558898,0.0002052658],"domain_scores_gemma":[0.9986425,0.0004282508,0.000370055,0.0004052015,0.0000628064,0.00009117821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006053561,0.0002166153,0.9918839,0.000004240485,0.0002537075,0.0003929614,0.00002166891,8.228248e-8,0.0001835938,0.00001273703,0.003842968,0.00258216],"study_design_scores_gemma":[0.00453671,0.0004968073,0.9918426,0.00004710837,0.00009899904,0.0001311252,0.000006574452,0.00000129632,0.000251585,0.00005868281,0.002477762,0.00005069315],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921828,0.0001133379,0.000001178256,0.006321842,0.0001587273,0.0003987383,0.00008237071,0.00001122301,0.0007297669],"genre_scores_gemma":[0.9980662,0.000234655,0.0001138163,0.0007723313,0.0001334509,0.00005501472,0.00002434711,0.00001334063,0.000586831],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005883398,"threshold_uncertainty_score":0.4145038,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121699071","doi":"10.1158/0008-5472.can-06-3607","title":"Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital","funders":"National Cancer Institute; National Science Council","keywords":"Prodrug; Neuroblastoma; Progenitor cell; Carboxylesterase; Pharmacology; In vivo; Cancer research; Suicide gene; Cell culture; Genetic enhancement; Cytotoxicity; Medicine; Stem cell; Enzyme; Biology; In vitro; Biochemistry; Cell biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.05281070467650965,"gpt":0.3901860075831745,"spread":0.3373753029066648,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001343904,0.0002978461,0.0004774481,0.0006616642,0.0002152812,0.00004787862,0.0006297516,0.00007635554,0.0005398603],"category_scores_gemma":[0.0009532468,0.0002432932,0.0001679087,0.00128419,0.0005333339,0.0001574366,0.000352497,0.0008506611,0.00005605768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002698747,"about_ca_system_score_gemma":0.0006255106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003675895,"about_ca_topic_score_gemma":0.0002640296,"domain_scores_codex":[0.9950761,0.0002720851,0.0004555915,0.0007016145,0.002122524,0.001372081],"domain_scores_gemma":[0.9962081,0.0008272851,0.00009943286,0.000962191,0.000805666,0.001097296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01023184,0.001194734,0.2632336,0.0005625997,0.0003221806,0.004349526,0.0002822066,0.000004700162,0.7061306,0.0000488558,0.00153714,0.01210203],"study_design_scores_gemma":[0.002886343,0.0006424664,0.5626437,0.0002641666,0.0000211948,0.00001755841,0.00005073837,0.00001735184,0.4331407,0.00005306798,0.0001331955,0.0001295697],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935746,0.003425548,0.00001172498,0.0008884202,0.0001973635,0.00120066,0.00009381607,0.000101592,0.0005062816],"genre_scores_gemma":[0.9967577,0.001129682,0.00003133339,0.00006763363,0.000286667,0.0001313869,0.00006091898,0.00009943028,0.001435265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2994101,"threshold_uncertainty_score":0.9921209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967063990","doi":"10.1073/pnas.0904606106","title":"HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells","year":2009,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroblastoma; Neural crest; Biology; Cancer research; Angiogenesis; Gene knockdown; Tumor progression; Pathology; Endocrinology; Cell biology; Cell culture; Embryo; Medicine; Cancer; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05309707766879466,"gpt":0.3520599657054491,"spread":0.2989628880366544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005145155,0.0001396474,0.0002203996,0.0003914933,0.0002043624,0.00003758723,0.0004625347,0.00003872361,0.00001762189],"category_scores_gemma":[0.0001806873,0.00009568802,0.0000729075,0.0009357814,0.0004320396,0.0004607831,0.00008492599,0.0003117521,0.000001995073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006130859,"about_ca_system_score_gemma":0.00004805198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000209,"about_ca_topic_score_gemma":0.000001111409,"domain_scores_codex":[0.997647,0.00002040885,0.0003899287,0.0003235823,0.001285314,0.0003337705],"domain_scores_gemma":[0.9993067,0.00006900877,0.000296058,0.00001443535,0.0001937541,0.0001200593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0001305406,0.0004857933,0.02386193,0.00005592675,0.00001419685,0.000001565848,0.0001897434,0.0001245255,0.9724069,0.002111979,0.0001087172,0.0005081602],"study_design_scores_gemma":[0.0008437932,0.0009017602,0.6933118,0.000119239,0.00001119142,0.00003270149,0.00007120238,0.003878202,0.2876698,0.01308033,0.000004136454,0.00007583325],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970159,0.0000129547,1.886484e-7,0.001203854,0.00001183522,0.0003144825,0.00001226161,0.00002266506,0.001405875],"genre_scores_gemma":[0.9989762,0.000005321404,0.0002241428,0.0006442367,0.00003357909,0.000005260407,5.947836e-7,0.000006940375,0.0001037505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6847371,"threshold_uncertainty_score":0.3902044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2571353014","doi":"10.1016/j.ccell.2016.12.002","title":"Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; St. Baldrick's Foundation; Ministero dell’Istruzione, dell’Università e della Ricerca; AbbVie; Janssen Biotech; Innovative Medicines Initiative; Associazione Italiana per la Ricerca sul Cancro; Wellcome; Merck; Takeda Pharmaceuticals U.S.A.; Pfizer; Boehringer Ingelheim","keywords":"Epigenetics; Druggability; Chromatin; Biology; Small interfering RNA; Cancer research; Methyltransferase; Genetics; Bioinformatics; Cell biology; RNA; Gene; Methylation","retraction":null,"screen_n_in":null,"score":{"opus":0.03744754336170057,"gpt":0.3529582167922486,"spread":0.3155106734305481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006555881,0.0001371415,0.0001814223,0.00005667427,0.0001356061,0.00007303761,0.00006427509,0.00007463228,0.0000580898],"category_scores_gemma":[0.0000475117,0.0001227122,0.00004483711,0.00004404252,0.00008796104,0.0001651848,0.00003955647,0.0001606031,0.00001292008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001165634,"about_ca_system_score_gemma":0.0001122975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001004795,"about_ca_topic_score_gemma":0.000294882,"domain_scores_codex":[0.9990484,0.00003207077,0.0001478192,0.0003222447,0.0001726435,0.0002767967],"domain_scores_gemma":[0.9993374,0.00006277487,0.0001145481,0.0002763425,0.00006381225,0.0001450705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001497463,0.0003440628,0.01595361,0.0002316776,0.00006478998,0.00007027842,0.0001046569,0.00001813633,0.934723,0.00005916168,0.0001630718,0.04677005],"study_design_scores_gemma":[0.005705947,0.0008954231,0.283749,0.0001242522,0.00007282841,0.000008800718,0.00003798693,0.0003319049,0.7076131,0.001240018,0.000104178,0.0001165643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980068,0.0001877946,0.00009097357,0.0004159664,0.00004941993,0.0007348938,0.00002992867,0.00001916387,0.0004650928],"genre_scores_gemma":[0.9986827,0.0004394829,0.0000561563,0.0001428294,0.0001037411,0.0001600632,0.00002525172,0.00002834584,0.000361392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2677954,"threshold_uncertainty_score":0.5004058,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4362522571","doi":"10.1038/s41591-023-02297-5","title":"Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Ignyta; Y-mAbs Therapeutics; Varian Medical Systems; St. Baldrick's Foundation; Pfizer; Actuate Therapeutics; Bristol-Myers Squibb; Eli Lilly and Company; Alex's Lemonade Stand Foundation for Childhood Cancer; V Foundation for Cancer Research","keywords":"Medicine; Internal medicine; Refractory (planetary science); Neuroblastoma; Chemotherapy; Cyclophosphamide; Adverse effect; Clinical trial; Gastroenterology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.03487887887345568,"gpt":0.3942430159057496,"spread":0.3593641370322939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004623964,0.0004129912,0.0008899053,0.0007854794,0.00008454334,0.0000143633,0.0002057635,0.0003412119,0.0002431131],"category_scores_gemma":[0.001178785,0.0002294133,0.00007964047,0.002076312,0.0002599412,0.0001143541,0.00004414692,0.001701925,0.000122817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001298925,"about_ca_system_score_gemma":0.0003279898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004778782,"about_ca_topic_score_gemma":0.0001921792,"domain_scores_codex":[0.9965432,0.0001511704,0.000579724,0.0007626213,0.001246954,0.0007163691],"domain_scores_gemma":[0.9979943,0.000493472,0.0001857186,0.0006852889,0.0001664623,0.0004747624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9110656,0.002387954,0.001527435,0.0001409629,0.0002720504,0.01105764,0.0009882469,0.000005467662,0.02105682,0.00002107396,0.03639854,0.01507818],"study_design_scores_gemma":[0.8644689,0.05516335,0.01021664,0.001078299,0.0001512513,0.000341573,0.0002070364,0.0008895263,0.004934637,0.00003114353,0.06217933,0.0003383081],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796699,0.00009833001,0.000006900922,0.01292162,0.0004330181,0.002315057,0.00003180937,0.0003374519,0.004185859],"genre_scores_gemma":[0.9892125,0.0002297987,0.0002054156,0.001661282,0.0009047232,0.0001138866,0.0002572928,0.0001006264,0.007314519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05277539,"threshold_uncertainty_score":0.9355202,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131690391","doi":"10.1158/0008-5472.can-15-0423","title":"WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; Ontario Institute for Cancer Research","funders":"Cancer Council NSW; Medical Research Council; Ministero dello Sviluppo Economico; University of New South Wales; Ontario Ministry of Economic Development and Innovation; Ontario Genomics Institute; Ontario Genomics; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"Neuroblastoma; Biology; Cancer research; Promoter; Histone; Molecular biology; Carcinogenesis; RNA interference; Mdm2; Gene expression; Regulation of gene expression; Gene; Cell culture; Genetics; RNA","retraction":null,"screen_n_in":null,"score":{"opus":0.1975364755830004,"gpt":0.4374035864360187,"spread":0.2398671108530183,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006501297,0.0002325554,0.0003375389,0.0005837337,0.0001495642,0.00006904799,0.0002962153,0.0001282935,0.0008571067],"category_scores_gemma":[0.0001018241,0.0001861595,0.00008764766,0.0006738477,0.0002793246,0.0003336278,0.0001155776,0.001048478,0.00008443721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004619928,"about_ca_system_score_gemma":0.001281126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002348642,"about_ca_topic_score_gemma":0.0002637817,"domain_scores_codex":[0.9955767,0.0005224969,0.0002483461,0.0007098612,0.001937935,0.001004706],"domain_scores_gemma":[0.9978809,0.00007672171,0.00003844516,0.0005143175,0.000414767,0.001074831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002979132,0.0009018908,0.01616637,0.0001077716,0.00003246994,0.002567095,0.0007389233,0.00003348159,0.9687475,0.00004363191,0.005991101,0.001690627],"study_design_scores_gemma":[0.01136564,0.00505288,0.2040082,0.000468634,0.00002432025,0.0004298197,0.0006308011,0.000342542,0.7629622,0.0008879889,0.01341861,0.0004084028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951381,0.0005390981,0.00001769443,0.001460605,0.0001182876,0.001797204,0.00006596988,0.00007121349,0.0007918451],"genre_scores_gemma":[0.9965607,0.0001405217,0.000323993,0.000146202,0.0002667212,0.0008234709,0.0001359196,0.00006172046,0.001540733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2057853,"threshold_uncertainty_score":0.9384717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015602128","doi":"10.1158/0008-5472.can-19-3068","title":"Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute; National Institutes of Health; CANDU Owners Group; Cancer Prevention and Research Institute of Texas","keywords":"Neuroblastoma; ATRX; Telomere; Biology; Cancer research; Oncology; Cancer; Internal medicine; Exome sequencing; Medicine; Gene; Cell culture; Genetics; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.1679903595228826,"gpt":0.4605438150124882,"spread":0.2925534554896057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001092984,0.0002241057,0.0005950603,0.0002905835,0.0001315508,0.00004402155,0.0003585416,0.0001353131,0.0006931428],"category_scores_gemma":[0.002146489,0.0001780337,0.0001610461,0.001310537,0.0002901523,0.0001010693,0.0003521908,0.002128035,0.001018443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002527771,"about_ca_system_score_gemma":0.000506237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007945212,"about_ca_topic_score_gemma":0.0002559316,"domain_scores_codex":[0.9955711,0.0006158391,0.0006169134,0.0008506691,0.00120638,0.001139113],"domain_scores_gemma":[0.9976208,0.0004838691,0.00007564633,0.0005071717,0.0003036398,0.001008904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01068305,0.001563695,0.8480536,0.0006267349,0.0003267511,0.01217063,0.000250063,0.00005629774,0.03295839,0.004972649,0.02571324,0.06262489],"study_design_scores_gemma":[0.02235056,0.01069433,0.9242388,0.0004148691,0.00007792654,0.00009316031,0.0002174295,0.0008773252,0.02609625,0.003470673,0.01094754,0.0005211313],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809392,0.0001893971,0.00009623813,0.01662331,0.0001554783,0.001012624,0.00007035206,0.00008822593,0.0008251517],"genre_scores_gemma":[0.9952129,0.001048834,0.0005290906,0.001589317,0.0002760247,0.0002411933,0.00000938125,0.0000699482,0.001023378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07618518,"threshold_uncertainty_score":0.9997594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056621958","doi":"10.1200/jco.2013.51.2038","title":"Ototoxicity in Children With High-Risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales—A Report From the Children's Oncology Group","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Children's Hospital of Pittsburgh; National Cancer Institute; University of Texas Health Science Center at San Antonio; University of California, Los Angeles; York University; City of Hope; Cedars-Sinai Medical Center; Children's Hospitals and Clinics of Minnesota; Seattle Children's Research Institute; Cincinnati Children's Hospital Medical Center; Tulane University; Virginia Commonwealth University; McGill University Health Centre; College of Engineering, Michigan State University; Children's National Hospital; Children's Mercy Hospital; University of South Carolina; Loma Linda University; McGill University; Dartmouth College; BC Children's Hospital; Children's Hospital Los Angeles; Louisiana State University; Children's Hospital of Philadelphia; Hospital for Sick Children; Georgetown University; West Virginia University; Kaiser Permanente; University of Illinois at Urbana-Champaign; Michigan State University; Cleveland Clinic; University of Minnesota; Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago","keywords":"Medicine; Ototoxicity; Common Terminology Criteria for Adverse Events; Concordance; Hearing loss; Carboplatin; Neuroblastoma; Grading (engineering); Population; Internal medicine; Cisplatin; Pediatrics; Audiology; Adverse effect; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02927050104966246,"gpt":0.3657615924739496,"spread":0.3364910914242871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00338336,0.0002553852,0.001858891,0.0001457225,0.00009350375,0.00001144764,0.0003026202,0.0003132777,0.00002176679],"category_scores_gemma":[0.007313537,0.00013513,0.0002854195,0.0002309572,0.0009071773,0.000143479,0.0001340719,0.002190546,0.000002652503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001148809,"about_ca_system_score_gemma":0.0005507505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001245318,"about_ca_topic_score_gemma":0.00082447,"domain_scores_codex":[0.994188,0.002223702,0.002201891,0.0004408212,0.0005702905,0.0003752619],"domain_scores_gemma":[0.9880024,0.007329684,0.003547271,0.0004205849,0.0002234757,0.0004765644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003413552,0.001710846,0.9687442,0.00001006457,0.0006397016,0.0004739751,0.00003777338,0.00001216566,0.00009517778,0.00002017061,0.0001956751,0.02464676],"study_design_scores_gemma":[0.0122012,0.02931622,0.954837,0.000129421,0.0005500643,0.001863077,0.00001586128,0.00004409687,0.000237494,0.0003603493,0.0003445153,0.0001006874],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979218,0.0001826979,0.0001372716,0.0006947295,0.0002440774,0.0006151292,0.00004730084,0.00001099773,0.0001459744],"genre_scores_gemma":[0.9955367,0.001876229,0.001746624,0.0002509159,0.0005318686,0.000006968254,0.000008681008,0.00002573794,0.00001626251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02760537,"threshold_uncertainty_score":0.9516953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027625542","doi":"10.1038/sj.onc.1206160","title":"A human brain tumor-derived PDGFR-α deletion mutant is transforming","year":2003,"lang":"en","type":"article","venue":"Oncogene","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Platelet-derived growth factor receptor; Mutant; Receptor tyrosine kinase; Cancer research; Molecular biology; Growth factor receptor; Transfection; Signal transduction; Cell biology; Cell growth; Receptor; Tyrosine kinase; Cell culture; Growth factor; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02806177110473869,"gpt":0.3188180201856512,"spread":0.2907562490809125,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001209421,0.0001405833,0.0002030947,0.00009937803,0.0001337433,0.00001492689,0.00004663999,0.0000402343,0.0006849707],"category_scores_gemma":[0.00005165941,0.0001190714,0.000105536,0.0001726878,0.00004411517,0.000055102,0.000008168486,0.0001287723,0.0001865869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001009596,"about_ca_system_score_gemma":0.0001131852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003143793,"about_ca_topic_score_gemma":0.00002709421,"domain_scores_codex":[0.9988587,0.00005636494,0.0001740084,0.0002539424,0.0003038462,0.0003531472],"domain_scores_gemma":[0.9994407,0.00002173238,0.00003225247,0.000212154,0.00005205486,0.000241049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007044693,0.0002628815,0.0004826275,0.00003163161,0.00006643302,0.0008572883,0.0001405144,4.394479e-7,0.9940175,0.000113663,0.0005524044,0.003404105],"study_design_scores_gemma":[0.003791931,0.001021397,0.001530788,0.00006173782,0.00005215902,0.0005480314,0.00005784853,0.0000156483,0.969889,0.0001920185,0.0227154,0.0001240623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892799,0.000108867,0.0001494696,0.0009878163,0.00003624509,0.0003985835,0.00001162035,0.00005595949,0.008971581],"genre_scores_gemma":[0.996437,0.00001856885,0.0004631861,0.001208344,0.00004846667,0.0000334929,0.00001638727,0.00003038862,0.001744151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02412858,"threshold_uncertainty_score":0.7499949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012716786","doi":"10.1016/s1476-5586(03)80017-9","title":"Chromosomal Localization of DNA Amplifications in Neuroblastoma Tumors Using cDNA Microarray Comparative Genomic Hybridization","year":2003,"lang":"en","type":"article","venue":"Neoplasia","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Comparative genomic hybridization; Amplicon; Biology; Copy number analysis; Copy-number variation; Complementary DNA; Microarray; Genetics; Gene duplication; Microarray analysis techniques; Gene expression profiling; Gene; Gene dosage; Neuroblastoma; Chromosome; Computational biology; Molecular biology; Genome; Polymerase chain reaction; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.03972326601490615,"gpt":0.3088302847914496,"spread":0.2691070187765435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007678697,0.0001565928,0.000297034,0.0002891151,0.00007629111,0.00001475453,0.0000618014,0.00004758122,0.0000797516],"category_scores_gemma":[0.00008583175,0.0001558351,0.00005548237,0.0005868478,0.0001013207,0.0001030042,0.00001599567,0.0001288494,0.00004447095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000161065,"about_ca_system_score_gemma":0.0002859323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004260132,"about_ca_topic_score_gemma":0.00006190257,"domain_scores_codex":[0.9986929,0.0001428296,0.0003711841,0.0002995575,0.0002259757,0.0002675001],"domain_scores_gemma":[0.9993059,0.00005849024,0.0001344986,0.0002500637,0.0001225555,0.0001284931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002599109,0.0008229708,0.08979125,0.0001011665,0.00005710667,0.000124474,0.000630061,0.004633278,0.9025974,0.0006541818,0.0001386409,0.0001896248],"study_design_scores_gemma":[0.004208142,0.0007306396,0.2073004,0.0002170336,0.00007458572,0.0005868219,0.000261529,0.01359938,0.7719747,0.000110487,0.0007083336,0.0002278773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949524,0.0000442557,0.003155576,0.00003817728,0.00005128865,0.0005802569,0.00001664799,0.0000286834,0.001132666],"genre_scores_gemma":[0.998657,0.00001118763,0.001085444,0.00004745186,0.00001801752,0.00001735321,0.00005707813,0.00002505215,0.00008142962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1306226,"threshold_uncertainty_score":0.6354769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1529762244","doi":"10.1002/pbc.24777","title":"Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project","year":2013,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"William Guy Forbeck Research Foundation; St. Baldrick's Foundation","keywords":"Medicine; Neuroblastoma; Disease; Internal medicine; Stage (stratigraphy); Oncology; Proportional hazards model; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.006112650145269083,"gpt":0.2484073045570639,"spread":0.2422946544117948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001238357,0.0003152363,0.0003106636,0.0002383446,0.0001114049,0.0001065481,0.000268423,0.00008951934,0.0001823903],"category_scores_gemma":[0.0002350093,0.0002209969,0.0001090536,0.000498033,0.00007865694,0.000244656,0.0002376594,0.0006457743,0.00005533899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006066851,"about_ca_system_score_gemma":0.0001758838,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01928264,"about_ca_topic_score_gemma":0.001886287,"domain_scores_codex":[0.997397,0.0001180542,0.0004655255,0.000780847,0.0007148797,0.0005236687],"domain_scores_gemma":[0.9988337,0.0001041324,0.0002414801,0.0004597556,0.0001387719,0.0002222302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003330244,0.0007230996,0.9893946,0.0000418997,0.0001362208,0.0005735282,0.000183719,0.000001174777,0.0001863531,4.906336e-7,0.004852602,0.003573256],"study_design_scores_gemma":[0.006660542,0.0003177559,0.9913692,0.0001607972,0.0003090362,0.0005634621,0.00003081119,0.0001534747,0.0001216208,0.00001490578,0.0001244413,0.0001738849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955162,0.00110475,0.000003934038,0.0007544063,0.0004341705,0.001833492,0.0001363623,0.00008228081,0.0001343507],"genre_scores_gemma":[0.9936872,0.003713002,0.00008265272,0.0005242305,0.001153216,0.000552538,0.00005625073,0.00005857343,0.0001723056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01739636,"threshold_uncertainty_score":0.9872481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011386610","doi":"10.1093/jnci/92.3.253","title":"Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects","year":2000,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Neuroblastoma; Liposome; Molecular biology; Biology; Monoclonal antibody; Western blot; Cationic liposome; In vitro; In vivo; Antibody; Cell culture; Biochemistry; Immunology; Transfection","retraction":null,"screen_n_in":null,"score":{"opus":0.01836404277908087,"gpt":0.3112103005800679,"spread":0.2928462578009871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001965188,0.0002141336,0.0004489317,0.0003825801,0.0001964058,0.00002741512,0.0003364869,0.0000550524,0.0001625272],"category_scores_gemma":[0.0001557943,0.0001459658,0.0003249147,0.0006023275,0.0001899316,0.0003248339,0.00007090984,0.000347884,0.00004244009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003032794,"about_ca_system_score_gemma":0.0005460644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001499474,"about_ca_topic_score_gemma":0.00006805754,"domain_scores_codex":[0.9975555,0.0001076055,0.0005895871,0.0001979798,0.001246584,0.000302732],"domain_scores_gemma":[0.9983838,0.0001093411,0.0003196116,0.0001987459,0.0007473547,0.0002411692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001603506,0.0005243371,0.001515037,0.0001421636,0.0005043059,0.0006146341,0.0001226291,0.002928233,0.9844579,0.00005326934,0.003826651,0.003707363],"study_design_scores_gemma":[0.003892035,0.001224176,0.1713412,0.0007885446,0.0002085898,0.0007699548,0.000005111558,0.00007248941,0.8177202,0.0001937371,0.003624262,0.0001596862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969651,0.0002781688,0.00001176818,0.0007904045,0.0008521182,0.0004452552,0.00006863513,0.00001459606,0.0005739643],"genre_scores_gemma":[0.9975235,0.0002151622,0.0003219903,0.0009034959,0.0004667948,0.000009642232,0.000003413525,0.00002748085,0.0005285577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1698262,"threshold_uncertainty_score":0.5952311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972000776","doi":"10.1158/0008-5472.can-10-2484","title":"Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PLK1; Cancer research; Neuroblastoma; Cytotoxic T cell; Kinase; Polo-like kinase; Biology; PI3K/AKT/mTOR pathway; Protein kinase B; Aurora kinase; Stem cell; Cancer; Medicine; Internal medicine; Cell cycle; Signal transduction; Cell biology; Cell culture; In vitro; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1219783853322647,"gpt":0.3743966627450988,"spread":0.2524182774128341,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007047799,0.0003296671,0.0004301294,0.0006205416,0.0004724633,0.0001189435,0.0004070985,0.0001053001,0.001021179],"category_scores_gemma":[0.0006049118,0.0002969421,0.0002265782,0.0007057887,0.0004118394,0.000188889,0.0003788493,0.0007671809,0.0004842701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002742207,"about_ca_system_score_gemma":0.0009275214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002246257,"about_ca_topic_score_gemma":0.000256884,"domain_scores_codex":[0.9957882,0.0003188532,0.0004043943,0.0008749377,0.00105766,0.00155593],"domain_scores_gemma":[0.997119,0.0003390374,0.00009307396,0.0006917738,0.0008620947,0.0008950148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005585702,0.001420872,0.00128963,0.0007705853,0.0002864185,0.00635239,0.0007897045,0.000004094634,0.9616404,0.0002055082,0.01911484,0.002539886],"study_design_scores_gemma":[0.003773551,0.004056324,0.001685314,0.0003339504,0.00004917512,0.00006672716,0.0003102994,0.0001523106,0.9857228,0.0004067244,0.003189223,0.0002536182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991756,0.000449324,0.00006571702,0.0004574779,0.000270087,0.002296261,0.0002265953,0.0001277809,0.004350706],"genre_scores_gemma":[0.9910331,0.00008960194,0.001195925,0.000522884,0.0004193278,0.001281504,0.00004872849,0.0001429436,0.005266023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02408241,"threshold_uncertainty_score":0.9999483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095202886","doi":"10.1038/cdd.2010.187","title":"CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression","year":2011,"lang":"en","type":"article","venue":"Cell Death and Differentiation","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Office of Science; National Cancer Institute; National Institutes of Health; Newcastle University; University of Oregon; McGill University","keywords":"Biology; Carcinogenesis; Neural crest; Neuroblastoma; Loss of heterozygosity; Cancer research; Epigenetics; Reprogramming; Transcription factor; Cell fate determination; Zinc finger; Gene expression; Enhancer; Zinc finger transcription factor; Tumor suppressor gene; Gene expression profiling; Cell biology; Gene; Genetics; Cell culture","retraction":null,"screen_n_in":null,"score":{"opus":0.02753566293484423,"gpt":0.2549909809669525,"spread":0.2274553180321083,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006496318,0.000314768,0.0003468222,0.0001377232,0.0002363371,0.00008012319,0.0001104312,0.00006832585,0.0001600735],"category_scores_gemma":[0.00008129787,0.0002541506,0.0001068142,0.0001452392,0.00006900159,0.0002959914,0.0001385827,0.0002027226,0.00003646197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003608818,"about_ca_system_score_gemma":0.00005569696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002659978,"about_ca_topic_score_gemma":0.00001180839,"domain_scores_codex":[0.9979762,0.0001064155,0.0003215508,0.0006612567,0.000378682,0.0005558381],"domain_scores_gemma":[0.9988503,0.00005515261,0.0001560766,0.0004286617,0.0001302791,0.0003795106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001486999,0.001253203,0.07534739,0.000470219,0.00008767026,0.001449107,0.0008932327,7.398829e-7,0.9177844,0.00007527331,0.0004628111,0.0006889854],"study_design_scores_gemma":[0.002513332,0.0006142579,0.1516802,0.00006993241,0.0001434714,0.0002433375,0.00003851807,0.0001919863,0.8439301,0.0002906352,0.00009627063,0.0001879044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961604,0.0003013684,0.0008245243,0.00003084243,0.0001564425,0.0006839629,0.00003931071,0.0001399862,0.001663091],"genre_scores_gemma":[0.9951507,0.0001681415,0.003757959,0.0001381676,0.0001104459,0.000115007,0.0001708867,0.00005365978,0.0003350129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07633284,"threshold_uncertainty_score":0.9999911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165240249","doi":"10.1523/jneurosci.20-20-07648.2000","title":"Evidence That Helix-Loop-Helix Proteins Collaborate with Retinoblastoma Tumor Suppressor Protein to Regulate Cortical Neurogenesis","year":2000,"lang":"en","type":"article","venue":"Journal of Neuroscience","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Killam Trusts","keywords":"Neurogenesis; Biology; Retinoblastoma protein; Progenitor cell; Transcription factor; Cell biology; Retinoblastoma; Basic helix-loop-helix; Mitosis; Progenitor; Cell cycle; Neuroscience; Gene; Genetics; DNA-binding protein; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.04309086530758606,"gpt":0.3023009492542991,"spread":0.2592100839467131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004603806,0.0003103569,0.0005123867,0.0003019446,0.0002599297,0.0001976075,0.0005278769,0.00004425289,0.0001516766],"category_scores_gemma":[0.001468069,0.0002077578,0.0001253156,0.001498113,0.0003723977,0.0006583866,0.00009148621,0.00052087,0.0000887784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009778587,"about_ca_system_score_gemma":0.0007618453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008776746,"about_ca_topic_score_gemma":0.000007150322,"domain_scores_codex":[0.9958293,0.0003016921,0.0005472579,0.000587828,0.00196495,0.0007689478],"domain_scores_gemma":[0.9971949,0.0001290119,0.0003607963,0.0005428219,0.0006047916,0.001167703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006147745,0.0005013872,0.002817495,0.00006389555,0.00001428445,0.01001371,0.00004937229,0.0001162319,0.9782529,0.000006672669,0.0002812156,0.001735052],"study_design_scores_gemma":[0.002114257,0.01692587,0.2302322,0.001443069,0.00008641972,0.008485881,0.0000208692,0.0002782674,0.7375652,0.000009648422,0.002593256,0.0002450407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926407,0.00008353965,0.00007138771,0.005422607,0.0001005276,0.001511979,0.00001232399,0.00004142322,0.0001155476],"genre_scores_gemma":[0.9944485,0.00007316336,0.001457541,0.001600367,0.00009631609,0.00005656611,2.099976e-7,0.0000460888,0.002221194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2406877,"threshold_uncertainty_score":0.8472118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2493582367","doi":"10.1016/j.ejca.2016.06.005","title":"Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Sick Kids Foundation; William Guy Forbeck Research Foundation; Super Jake Foundation; Children's Neuroblastoma Cancer Foundation","keywords":"Neuroblastoma; Medicine; Oncology; Stage (stratigraphy); Disease; Internal medicine; Database; Computer science; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01454905375888124,"gpt":0.2666189714566038,"spread":0.2520699176977226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003630612,0.000162864,0.0003052314,0.0001421716,0.00002589619,0.00001598516,0.0002609443,0.000004120612,0.00007149456],"category_scores_gemma":[0.0003999016,0.00007955815,0.00005747318,0.0001462955,0.0001567198,0.0001829044,0.0001201568,0.0002050254,0.000002932561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000386407,"about_ca_system_score_gemma":0.0001127468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001879645,"about_ca_topic_score_gemma":0.0001131565,"domain_scores_codex":[0.9976496,0.0006081875,0.0005248801,0.0002280765,0.0008154879,0.0001737743],"domain_scores_gemma":[0.9981889,0.0004023327,0.000637767,0.0002740276,0.0002860438,0.0002109198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005442832,0.001150435,0.9738843,0.00003813986,0.0003763613,0.001404108,0.0003201037,0.00004778509,0.002479151,4.4817e-7,0.00005703472,0.01479933],"study_design_scores_gemma":[0.01138624,0.004061822,0.9829169,0.0006902639,0.0002850959,0.00000475443,0.00009469892,0.00003781187,0.0003351715,0.000002710517,0.0001167839,0.00006773886],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978931,0.0001605363,0.0001966023,0.0004099314,0.00007923167,0.0006173921,0.0006241289,0.000004115377,0.00001496541],"genre_scores_gemma":[0.9995825,0.0001330936,0.00007993699,0.00004759354,0.00006842057,0.000008569641,0.000004360298,0.00003510235,0.00004045829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01473159,"threshold_uncertainty_score":0.3244287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017530122","doi":"10.1210/jcem.85.5.6589","title":"Pediatric Adrenocortical Tumors: Molecular Events Leading to Insulin-Like Growth Factor II Gene Overexpression*","year":2000,"lang":"en","type":"review","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Loss of heterozygosity; Endocrinology; Internal medicine; Virilization; Biology; Insulin-like growth factor 2; Locus (genetics); DNA methylation; Cancer research; Medicine; Gene expression; Gene; Genetics; Allele; Androgen","retraction":null,"screen_n_in":null,"score":{"opus":0.08955589143194263,"gpt":0.4380596241869682,"spread":0.3485037327550256,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009358888,0.000776328,0.005564023,0.0007936569,0.0002050852,0.00002051884,0.001209191,0.0004623783,0.0004856509],"category_scores_gemma":[0.0032267,0.0004237609,0.002255063,0.0006902227,0.0002361844,0.0001232774,0.000604532,0.003960121,0.0005460863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008769552,"about_ca_system_score_gemma":0.001421963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001169746,"about_ca_topic_score_gemma":4.036097e-7,"domain_scores_codex":[0.9904711,0.002526897,0.003924562,0.0006005033,0.001271536,0.001205357],"domain_scores_gemma":[0.9936919,0.00202154,0.00157955,0.0009119607,0.0003884646,0.001406559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003223066,0.003388724,0.0003131834,0.002036361,0.004010919,0.009224677,0.00007752632,0.00000372941,0.00008816103,0.0002755767,0.003467959,0.9738901],"study_design_scores_gemma":[0.006234495,0.003419207,0.003488818,0.003802032,0.009591738,0.01025845,0.000004616846,8.324683e-7,0.0001807952,0.000488768,0.9620118,0.0005185101],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08498249,0.9119033,0.00003219851,0.0006053458,0.0009226411,0.001255554,0.0000613092,0.00003762664,0.0001995935],"genre_scores_gemma":[0.008007747,0.9867184,0.0006165996,0.001073705,0.002934167,0.00003324694,0.00001396398,0.0001288682,0.0004733547],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9733716,"threshold_uncertainty_score":0.9998214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109781325","doi":"10.1093/aje/154.2.106","title":"Parental Occupational Exposures to Chemicals and Incidence of Neuroblastoma in Offspring","year":2001,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Odds ratio; Incidence (geometry); Confidence interval; Offspring; Neuroblastoma; Logistic regression; Occupational medicine; Environmental health; Demography; Toxicology; Occupational exposure; Pediatrics; Pregnancy; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04013415342199754,"gpt":0.3809091050698951,"spread":0.3407749516478976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006475047,0.00008985609,0.0006104386,0.0002681759,0.00001290283,0.000001319683,0.00008377453,0.00002278036,0.00002763296],"category_scores_gemma":[0.003447484,0.00006907481,0.0000672412,0.000250072,0.0002775869,0.00005170238,0.00005288797,0.0001975738,0.000003074182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004423291,"about_ca_system_score_gemma":0.00008730739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001541504,"about_ca_topic_score_gemma":0.00002451067,"domain_scores_codex":[0.9985517,0.0002700266,0.0006366562,0.0001460208,0.0001444646,0.0002510879],"domain_scores_gemma":[0.9978563,0.001303992,0.0003539209,0.0001051504,0.00009928909,0.0002814093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001668596,0.0001177913,0.9572471,0.000007710572,0.00003594823,0.0003028963,0.00005499526,0.00005097061,0.02497538,0.00003269867,0.0001184928,0.01538746],"study_design_scores_gemma":[0.0008045916,0.003582141,0.9904335,0.000104095,0.00001333121,0.001904634,0.0000723187,0.0000517433,0.002669179,0.0001398097,0.0001816319,0.00004300384],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979727,0.000142793,0.0002029914,0.001502069,0.00002862736,0.00008500248,0.000002115272,0.000002782942,0.00006091628],"genre_scores_gemma":[0.9950284,0.0002172102,0.003862623,0.0008224812,0.0000492932,0.000002992565,8.814802e-7,0.000006973994,0.000009117451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03318647,"threshold_uncertainty_score":0.4127209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019034957","doi":"10.1097/00001648-200101000-00005","title":"Residential Pesticide Exposure and Neuroblastoma","year":2001,"lang":"en","type":"article","venue":"Epidemiology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Neuroblastoma; Odds ratio; Confidence interval; Pesticide; Medicine; Cancer; Case-control study; Telephone interview; Pediatric oncology; Pediatrics; Environmental health; Internal medicine; Oncology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0510018118282187,"gpt":0.3560353324641762,"spread":0.3050335206359575,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000337216,0.0001327297,0.00038292,0.0001131398,0.00007624243,0.000004393858,0.00005441026,0.00008874211,0.0002496895],"category_scores_gemma":[0.002610373,0.0001044959,0.00006316147,0.0001083312,0.0001753761,0.00004671147,0.00007045114,0.0002329167,0.0001945642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002009399,"about_ca_system_score_gemma":0.00004237727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000676779,"about_ca_topic_score_gemma":0.00003611471,"domain_scores_codex":[0.9985068,0.0003240691,0.0002715467,0.0003461833,0.00009524205,0.0004560861],"domain_scores_gemma":[0.9983602,0.0009655987,0.00005606984,0.0002499698,0.00004001208,0.0003282139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001302871,0.0001885152,0.9608582,0.00004079513,0.0001125242,0.004024643,0.00003822864,0.00001008825,0.00509,0.001171874,0.01296933,0.01419295],"study_design_scores_gemma":[0.001685028,0.001718452,0.9814093,0.00002479626,0.00004574568,0.003646534,0.000009005574,0.0001687217,0.0003793551,0.001914244,0.008917557,0.0000812798],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987315,0.0004849957,0.0001993506,0.009204051,0.0001120222,0.0002096352,0.000002141383,0.00007473317,0.002398048],"genre_scores_gemma":[0.9938558,0.0004069907,0.000812572,0.002372266,0.0002225708,0.00001897985,0.000007120161,0.00001852965,0.002285134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0205511,"threshold_uncertainty_score":0.426122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2758777848","doi":"10.1007/s00259-017-3829-7","title":"Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials","year":2017,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute; Children's Neuroblastoma Cancer Foundation; Cancer Research UK; Alex's Lemonade Stand Foundation for Childhood Cancer; Cancer Research Institute","keywords":"Cog; Neuroblastoma; Medicine; Oncology; Internal medicine; Clinical trial; Computer science; Biology; Artificial intelligence; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05543207068529071,"gpt":0.3852522822265522,"spread":0.3298202115412615,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00411577,0.0001682964,0.0005004575,0.0001990161,0.0003237623,0.00009629166,0.000321745,0.0000120591,0.000025603],"category_scores_gemma":[0.003146786,0.00008936007,0.0001183362,0.0001047119,0.0002598443,0.0002182123,0.0003086967,0.0005187052,0.000002945492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002165685,"about_ca_system_score_gemma":0.00004431772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001903116,"about_ca_topic_score_gemma":0.000005726189,"domain_scores_codex":[0.9965359,0.001769317,0.0007210014,0.0002104362,0.0005604243,0.0002029247],"domain_scores_gemma":[0.9980562,0.0002065805,0.0009752355,0.0004434079,0.0001518752,0.0001666406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00169144,0.000359956,0.06716808,0.0001883835,0.0006171913,0.0080281,0.002806886,0.000179479,0.7632657,0.000599939,0.001588964,0.1535059],"study_design_scores_gemma":[0.02018385,0.001488914,0.9473614,0.002314742,0.001192604,0.002838664,0.001085614,0.0008877077,0.0193661,0.0004795645,0.002581492,0.0002193302],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986351,0.0004924577,0.000305913,0.01134369,0.000194266,0.0004040254,0.000002898899,0.000005315302,0.0009004362],"genre_scores_gemma":[0.9976447,0.0002279156,0.001229167,0.0006795123,0.0001554335,8.318331e-7,0.000001101406,0.00004170176,0.00001962384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8801934,"threshold_uncertainty_score":0.3767224,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966169774","doi":"10.1159/000336483","title":"Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Internal medicine; Regimen; Mitoxantrone; Progressive disease; Chemotherapy; Refractory (planetary science); Etoposide; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01711074645537189,"gpt":0.3305496907564193,"spread":0.3134389443010475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052227,0.00009778763,0.0001905658,0.00007723305,0.00003736309,0.000004226761,0.00008568379,0.00003935996,0.0001223232],"category_scores_gemma":[0.00002265964,0.00005450435,0.00002755564,0.0001695606,0.00008988452,0.00008745427,0.00002884981,0.0001383928,0.00007898689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002264364,"about_ca_system_score_gemma":0.00009280851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002635944,"about_ca_topic_score_gemma":0.00003828155,"domain_scores_codex":[0.9991537,0.00006954872,0.000101772,0.000150964,0.0001140479,0.0004099055],"domain_scores_gemma":[0.9994645,0.0001320834,0.00004882537,0.0002094874,0.00002182772,0.0001232655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003839349,0.003121776,0.9569929,0.00003829785,0.00008847668,0.0002332316,0.006549099,0.000005815695,0.01161649,0.00008355745,0.001986822,0.01544416],"study_design_scores_gemma":[0.01612583,0.00432528,0.9257829,0.0000206376,0.0000513814,0.0001333983,0.002102392,0.00004207379,0.007852668,0.000004589614,0.04340998,0.0001488514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957669,0.0003414366,0.00001658856,0.001535067,0.00006006571,0.0004946992,9.248162e-7,0.00001629858,0.001768059],"genre_scores_gemma":[0.9973407,0.0001387566,0.0006731878,0.0008625916,0.00008631573,0.0001953122,0.000002112113,0.00001484453,0.0006861252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04142316,"threshold_uncertainty_score":0.2222623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3179702411","doi":"10.1200/jco.21.00703","title":"Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Neuroblastoma; Refractory (planetary science); Irinotecan; Clinical endpoint; Internal medicine; Surgery; Vorinostat; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1137092475981462,"gpt":0.4651826797140354,"spread":0.3514734321158892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001687865,0.0002579096,0.002826951,0.0001465548,0.00009475482,0.00001445155,0.00009997216,0.0002797537,0.00008683263],"category_scores_gemma":[0.03587889,0.0001574389,0.0004536011,0.0001392973,0.0006716448,0.0001224871,0.0001244644,0.0007720633,0.000001352465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008041315,"about_ca_system_score_gemma":0.002639641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004044925,"about_ca_topic_score_gemma":0.0001090817,"domain_scores_codex":[0.994827,0.0009258782,0.002806376,0.0004692441,0.0006243465,0.0003471956],"domain_scores_gemma":[0.9768046,0.01832941,0.00262454,0.0003365936,0.001158996,0.0007459332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9568937,0.01183366,0.001574674,0.00005129581,0.001747163,0.009245574,0.00003830048,3.122684e-7,0.0002547806,0.000005443102,0.001302141,0.01705298],"study_design_scores_gemma":[0.778371,0.2025206,0.005836957,0.000114023,0.001645562,0.0002362111,0.00003993794,0.00002981921,0.0002878441,0.00002175939,0.010791,0.0001052516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945583,0.0002284127,0.00003880502,0.001366172,0.002309657,0.001225186,0.00008270711,0.000009644342,0.0001811473],"genre_scores_gemma":[0.9936695,0.0007452178,0.004433359,0.0001543805,0.0005645942,0.0000291556,0.00004764172,0.0000364226,0.0003197743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.190687,"threshold_uncertainty_score":0.9722423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168240861","doi":"10.1002/pbc.20777","title":"Evaluation of semi‐quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma","year":2006,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Research Resources; National Cancer Institute; Frank A. Campini Foundation; University of California, San Francisco; Dougherty Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Concordance; Scoring system; Neuroblastoma; Soft tissue; Correlation; Concordance correlation coefficient; Internal medicine; Nuclear medicine; Radiology; Surgery; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.02344335902251954,"gpt":0.2967891252404305,"spread":0.273345766217911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000479907,0.0002092504,0.0004220812,0.000402876,0.00005677293,0.00001184753,0.00007963985,0.00005554505,0.00002492917],"category_scores_gemma":[0.0001448754,0.0001663779,0.00008583888,0.0008029091,0.00003300979,0.0001359016,0.00002489332,0.0001400094,0.000004890569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002376619,"about_ca_system_score_gemma":0.0005128219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006542467,"about_ca_topic_score_gemma":0.0004488383,"domain_scores_codex":[0.9974391,0.0001326393,0.000414519,0.000409088,0.001214692,0.0003899321],"domain_scores_gemma":[0.9982672,0.0001501646,0.0002441597,0.0002359968,0.0009964688,0.0001059812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002832463,0.00183748,0.9883706,0.001256653,0.000360581,0.000030549,0.00008075577,0.002232372,0.001526054,0.0001487704,0.0002433634,0.001080363],"study_design_scores_gemma":[0.03426268,0.004119762,0.9418133,0.0003450571,0.004508956,0.000005898562,0.00005278745,0.001958551,0.01265243,0.00003975589,0.00001505547,0.0002257527],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961761,0.001016321,0.0000550823,0.00004264985,0.0001247764,0.002099742,0.0001178831,0.000041329,0.0003261776],"genre_scores_gemma":[0.9986024,0.00004017765,0.0004992409,0.00001041935,0.0001709969,0.000528257,0.00004401004,0.00004761498,0.00005685399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04655728,"threshold_uncertainty_score":0.6784692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156902079","doi":"10.1158/1078-0432.ccr-11-0078","title":"Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Hospital for Sick Children; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Topotecan; Medicine; Pharmacology; Angiogenesis; In vivo; Neuroblastoma; Cancer research; Pharmacokinetics; Rhabdomyosarcoma; Cancer; Chemotherapy; Oncology; Sarcoma; Internal medicine; Cell culture; Biology; Sunitinib; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.3053773045261252,"gpt":0.4944461548165539,"spread":0.1890688502904287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114149,0.0002036974,0.0007057254,0.0006039347,0.0000745367,0.00001570345,0.0003857279,0.0001218168,0.0005660239],"category_scores_gemma":[0.0003221399,0.0001543442,0.000169628,0.0008330503,0.0005604578,0.0002660243,0.0002063314,0.0009868474,0.00003795935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003040492,"about_ca_system_score_gemma":0.001597582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002780627,"about_ca_topic_score_gemma":0.0009085449,"domain_scores_codex":[0.9963334,0.0006035311,0.000582425,0.0007441992,0.0008629503,0.0008735576],"domain_scores_gemma":[0.9975092,0.0003059564,0.0002820302,0.0007268575,0.0005063941,0.0006695588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08119205,0.01235864,0.8478297,0.0005474279,0.0016526,0.005578385,0.003567901,0.00006891185,0.005305234,0.0001771353,0.002618426,0.03910359],"study_design_scores_gemma":[0.03082438,0.04039268,0.6325545,0.0005390817,0.0004593665,0.0001005317,0.001640182,0.002925341,0.2873304,0.002290642,0.00009982983,0.0008431345],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973104,0.0003987014,0.00001082304,0.0001835674,0.00003538855,0.001003254,0.0000962134,0.00002341613,0.0009382268],"genre_scores_gemma":[0.9973671,0.001092115,0.0004119243,0.000089407,0.0001598757,0.0001819655,0.00001027339,0.00005727336,0.0006300326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2820251,"threshold_uncertainty_score":0.6293973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012687605","doi":"10.1097/mph.0b013e318299d637","title":"Current and Future Strategies for Relapsed Neuroblastoma","year":2013,"lang":"en","type":"review","venue":"Journal of Pediatric Hematology/Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Topotecan; Irinotecan; Oncology; Temozolomide; Immunotherapy; Internal medicine; Refractory (planetary science); Chemotherapy; Disease; Targeted therapy; Intensive care medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.06367707080064555,"gpt":0.4141367188244433,"spread":0.3504596480237978,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004779323,0.0005774515,0.004134532,0.001092102,0.0001021504,0.00004346987,0.0002893131,0.0008487139,0.00007646388],"category_scores_gemma":[0.0002991089,0.0003748514,0.0008918183,0.0004003744,0.0001775418,0.0001932947,0.0001198268,0.001781405,0.00006790878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002800782,"about_ca_system_score_gemma":0.005070486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001109622,"about_ca_topic_score_gemma":0.000001557404,"domain_scores_codex":[0.9963507,0.0004769483,0.001684527,0.0004433971,0.0003706757,0.0006737188],"domain_scores_gemma":[0.9951439,0.001373372,0.001973437,0.0002983034,0.0005277701,0.0006831404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000302692,0.0007692262,0.00003441719,0.02208329,0.0005724925,0.002349832,0.00005645596,3.928191e-8,0.00000126551,0.0007063543,0.04601676,0.9271072],"study_design_scores_gemma":[0.003315724,0.007243141,0.00002250474,0.0006941925,0.004183055,0.02761585,0.00008272947,0.000001602451,8.591542e-7,0.0003781269,0.9562526,0.0002095861],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001182584,0.9941332,0.00005317769,0.0007560577,0.001823366,0.001760859,0.00002960556,0.00002527547,0.0002358121],"genre_scores_gemma":[0.00004359873,0.9934548,0.001502894,0.00005802521,0.004599466,0.0001647532,0.00002064528,0.0000803279,0.00007548156],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9268976,"threshold_uncertainty_score":0.9998704,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128653564","doi":"","title":"Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"In vivo; Melanoma; In vitro; Cancer research; Liposome; Oncogene; Neuroblastoma; Cationic liposome; Apoptosis; Monoclonal antibody; Medicine; Pharmacology; Biology; Immunology; Cell culture; Antibody; Transfection; Biochemistry; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.02716445340812738,"gpt":0.2434002716511696,"spread":0.2162358182430422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002030075,0.0002308834,0.0003901195,0.0003399715,0.0001042865,0.00005786667,0.00004646195,0.00005315775,0.00001111997],"category_scores_gemma":[0.0002623585,0.000196847,0.0000468425,0.0003048135,0.0001459565,0.0002542883,0.00006554952,0.0002167863,0.000002757219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003926494,"about_ca_system_score_gemma":0.00002951441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001733427,"about_ca_topic_score_gemma":0.00002957331,"domain_scores_codex":[0.9982547,0.0001531961,0.0002590296,0.0004456579,0.0002783761,0.0006090348],"domain_scores_gemma":[0.9991665,0.00008122342,0.00005583659,0.0001910206,0.00004510287,0.0004602457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002724771,0.005836337,0.6638476,0.0016679,0.001697675,0.008784726,0.001275588,0.00001622979,0.2330262,0.02367726,0.001060394,0.05638526],"study_design_scores_gemma":[0.006623407,0.000411823,0.4754387,0.00005955245,0.0001499953,0.0004833482,0.00009343553,0.00006244416,0.514312,0.002025208,0.00004274771,0.0002973205],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956309,0.0006513774,0.000002726508,0.0002381811,0.00002644785,0.001015917,0.00002793452,0.0000511681,0.0023553],"genre_scores_gemma":[0.9988362,0.0001358823,0.0003059725,0.0001660961,0.0000221438,0.0003977285,0.00001310023,0.00003675932,0.00008610549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2812859,"threshold_uncertainty_score":0.8027189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2752019124","doi":"10.2967/jnumed.117.195883","title":"Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1","year":2017,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Neuroblastoma; Internal medicine; Group (periodic table); Oncology; Pediatric oncology; Medical physics; Cancer; Physics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02286401340540922,"gpt":0.327347591184418,"spread":0.3044835777790088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001050609,0.0001942382,0.0007394829,0.0004913117,0.000177253,0.00002523286,0.000211838,0.0001140795,0.0001200935],"category_scores_gemma":[0.002353082,0.0001330919,0.0000842182,0.0001201169,0.0003570628,0.0003315796,0.0001164676,0.0007110711,0.000009446221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001342051,"about_ca_system_score_gemma":0.00008731132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007157723,"about_ca_topic_score_gemma":0.00005036112,"domain_scores_codex":[0.9976966,0.0002040741,0.0008345867,0.000285662,0.0007251289,0.0002539271],"domain_scores_gemma":[0.9972966,0.000181894,0.001546223,0.0004647114,0.0001976658,0.00031294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0257723,0.005523046,0.5664458,0.0003020435,0.0009230729,0.02724694,0.001273204,0.00003143355,0.2759092,0.0005054477,0.01022585,0.0858417],"study_design_scores_gemma":[0.0109649,0.0225477,0.9558741,0.0009257531,0.0002345629,0.006556694,0.00008360272,0.00002272186,0.001754096,0.0001950483,0.0007543025,0.00008653588],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923213,0.00007372653,0.000003298676,0.006144027,0.000368124,0.0004306106,0.000004555366,0.000009862443,0.0006445053],"genre_scores_gemma":[0.9982166,0.0006487569,0.0003158474,0.0002259686,0.0004830413,0.000002432887,0.00001054071,0.00003724412,0.00005962644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3894283,"threshold_uncertainty_score":0.5427328,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016358793","doi":"10.1200/jco.19.03285","title":"Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; William Guy Forbeck Research Foundation; Bear Necessities Pediatric Cancer Foundation; Super Jake Foundation; Children’s Oncology Group; American Society of Clinical Oncology; St. Baldrick's Foundation; Rally Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Karyorrhexis; Neuroblastoma; Mitotic index; Oncology; Pathology; Internal medicine; Mitosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1623469264939458,"gpt":0.4551598175571616,"spread":0.2928128910632158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001031353,0.0002579006,0.001605249,0.0003359758,0.00004753717,0.00003437639,0.000255405,0.0002744973,0.00002820471],"category_scores_gemma":[0.01849204,0.0001902663,0.0002552029,0.00044228,0.0002991041,0.0002589877,0.0001584907,0.00218032,0.00002127792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009183044,"about_ca_system_score_gemma":0.001582563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006833731,"about_ca_topic_score_gemma":0.0003515883,"domain_scores_codex":[0.9954624,0.001037772,0.001931858,0.0004535958,0.0006429922,0.0004714362],"domain_scores_gemma":[0.9930202,0.004226125,0.001119996,0.0001940716,0.0002458723,0.00119367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005471664,0.004675172,0.9022095,0.0001341708,0.0001961365,0.06881835,0.0001892189,0.0000103519,0.0001923896,0.00001063053,0.001631019,0.01646135],"study_design_scores_gemma":[0.01384649,0.03916332,0.9412662,0.0001642499,0.0002111811,0.002013077,0.0001872219,0.0002655461,0.00009004304,0.0001618598,0.00249192,0.0001388873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905742,0.0002980509,0.00001422463,0.007752734,0.0003156856,0.0007844146,0.000006743633,0.00002286806,0.0002310454],"genre_scores_gemma":[0.9945727,0.0005059704,0.0003400098,0.003799827,0.0006824535,0.00002487481,0.000004024952,0.00003960089,0.00003056325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06680527,"threshold_uncertainty_score":0.9897756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3042190218","doi":"10.1016/j.ejca.2020.05.010","title":"Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma","year":2020,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"Fondation contre le Cancer; Vlaamse regering; Kom op tegen Kanker; Fonds Wetenschappelijk Onderzoek; National Cancer Institute; Cancer Research UK; Neuroblastoma UK; Oak Foundation; Olivia Fund; Instituto de Salud Carlos III; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Neuroblastoma; Medicine; Clinical trial; Drug development; Drug; ATRX; Oncology; Pharmacology; Internal medicine; Biology; Mutation; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.04454238105661854,"gpt":0.3303695918244042,"spread":0.2858272107677856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005399386,0.0007160865,0.001925569,0.0002959557,0.0002142896,0.00006563923,0.0007515871,0.00007441912,0.00005511311],"category_scores_gemma":[0.0001136494,0.0004452984,0.0005106124,0.0007485848,0.000261598,0.0002052832,0.0004208104,0.0009358946,0.000001246382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003131804,"about_ca_system_score_gemma":0.005179662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009677792,"about_ca_topic_score_gemma":0.0001184607,"domain_scores_codex":[0.9957271,0.0004713622,0.00193565,0.000633125,0.0007225064,0.0005102576],"domain_scores_gemma":[0.9941679,0.0005941108,0.003192507,0.0002621336,0.001517902,0.000265495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001326613,0.0003214612,0.0009505285,0.003027429,0.005060992,0.00006789657,0.001439847,0.00002554139,0.0003536804,0.000005677123,0.01301269,0.9744076],"study_design_scores_gemma":[0.006334264,0.002024049,0.01243862,0.005902158,0.0009029194,0.0001932429,0.0001647055,0.00002110319,0.00237362,0.000003782393,0.9692184,0.000423166],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1356644,0.8544197,0.0002099166,0.002299285,0.0009606594,0.004630711,0.001470804,0.000037701,0.0003067919],"genre_scores_gemma":[0.01312421,0.9702139,0.01040731,0.001104083,0.001426859,0.0003495537,0.0001491929,0.0005181158,0.00270672],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9739845,"threshold_uncertainty_score":0.9997999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935510920","doi":"10.1016/j.ejca.2019.02.003","title":"Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Internal medicine; Confidence interval; Odds ratio; Oncology; Neuroblastoma; Induction chemotherapy; Univariate analysis; Stage (stratigraphy); Logistic regression; Multivariate analysis; Chemotherapy; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01246067678897274,"gpt":0.2864817174599867,"spread":0.274021040671014,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007677925,0.0001408625,0.00035942,0.0002040043,0.00003107053,0.00001307837,0.000193196,0.00002871406,0.0002182701],"category_scores_gemma":[0.000277344,0.00008371293,0.0001285176,0.0002378832,0.00006225987,0.00008142341,0.00006102201,0.0005445706,0.00002243771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001154691,"about_ca_system_score_gemma":0.000209555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002904767,"about_ca_topic_score_gemma":0.00005805099,"domain_scores_codex":[0.9971859,0.001321483,0.0005681342,0.0002063466,0.0005103022,0.0002078557],"domain_scores_gemma":[0.9986126,0.0002171445,0.0005240625,0.0003074548,0.0001605675,0.0001781027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04333436,0.0006993806,0.7450865,0.000005121185,0.0007278201,0.002756434,0.0008012095,0.0001047788,0.1399668,0.00000136287,0.002194337,0.06432188],"study_design_scores_gemma":[0.006737277,0.008030239,0.9769018,0.0001293814,0.00008097953,0.0003320039,0.00003232548,0.000002463165,0.004277756,0.000005022874,0.003413565,0.00005715219],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966463,0.0002309885,0.00002259468,0.00169367,0.0007847693,0.0004702866,0.00002668373,0.000008283821,0.000116415],"genre_scores_gemma":[0.9985539,0.0003874437,0.00006727471,0.0001760654,0.0005726961,0.000004470492,0.000004041787,0.00003688353,0.0001972726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2318153,"threshold_uncertainty_score":0.3413714,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}